Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment

Clinical trial NCT06228560 · COMPLETED

Trial details

NCT number: NCT06228560
Sponsor: Longbio Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Spontaneous Urticaria

Start date: 2024-01-26
Primary completion: 2025-04-17
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.